Post-stroke motor recovery processes remain unknown. Timescales and patterns of upper-limb (UL) recovery suggest a major impact of biological factors, with modest contributions from rehabilitation. We ...

Botulinum toxin type A was first used for the treatment of spasticity in 1989. A small uncontrolled study of treatment of upper limb spasticity after stroke reported encouraging benefits, including ...

University of Pittsburgh School of Medicine researchers report the final outcomes of a pioneering pilot clinical trial using ...

Determine the impact of motor control characteristics attributed to spasticity, such as spasms, stiffness, and clonus on the daily life of people with spinal cord injury (SCI). The experience of ...

Spasticity may be a term that’s new to you, but it’s a condition that affects more than 12 million people around the world. [8] It’s a complicated condition, but simply put, it’s extreme muscle ...

Few people know that botulinum toxin type A — BoNTA, better known by its trade name Botox — can do a lot more than perk up social lives by ironing out wrinkles and drying up overactive sweat glands.

Spasticity is involuntary overactivity of muscles that occurs following upper motor neuron damage to the brain or spinal cord. Upper limb spasticity is common after stroke and can cause deformity, ...